Farmeconomia-Health Economics and Therapeutic Pathways

Scope & Guideline

Advancing health economics for a healthier tomorrow.

Introduction

Welcome to the Farmeconomia-Health Economics and Therapeutic Pathways information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Farmeconomia-Health Economics and Therapeutic Pathways, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN1721-6915
PublisherSEED MEDICAL PUBLISHERS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationFARMECONOMIA / Farmeconomia
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA MAGENTA, 35, TORINO 10128, ITALY

Aims and Scopes

The journal 'Farmeconomia-Health Economics and Therapeutic Pathways' focuses on the intersection of health economics and therapeutic strategies. It aims to provide insights into the economic aspects of healthcare decisions, emphasizing cost-effectiveness, budget impact, and quality of life assessments in various therapeutic areas.
  1. Health Economics and Pharmacoeconomics:
    The journal emphasizes the economic evaluation of healthcare interventions, including cost-effectiveness analyses and pharmacoeconomic assessments to inform drug pricing and reimbursement decisions.
  2. Health Technology Assessment (HTA):
    It covers comprehensive evaluations of health technologies, assessing their clinical effectiveness, safety, and economic impact, which is essential for informed policy-making.
  3. Real-World Evidence (RWE):
    The journal highlights the importance of real-world evidence in understanding treatment effectiveness and patient outcomes outside controlled clinical trials.
  4. Patient-Centered Outcomes:
    Research often focuses on the impact of treatments on patient quality of life and healthcare resource utilization, ensuring that patient perspectives are central to economic evaluations.
  5. Cost Analysis in Specific Disease Areas:
    The scope includes detailed economic analyses for various diseases, such as diabetes, cancer, and mental health disorders, providing insights into the financial implications of different treatment strategies.
The journal is currently witnessing several emerging themes that reflect the evolving landscape of healthcare economics and therapeutic pathways. These trends highlight the increasing complexity of healthcare decisions and the importance of comprehensive evaluations.
  1. Long-Acting Injectable Therapies:
    There is a growing focus on the clinical and economic potential of long-acting injectable therapies, particularly in mental health and chronic conditions, reflecting a shift towards treatments that improve adherence and outcomes.
  2. Biosimilars and Their Economic Implications:
    Research on biosimilars, including their procurement and budget impact, is trending upward as healthcare systems look for cost-effective alternatives to expensive biologics.
  3. Budget Impact Analyses in Vaccination Programs:
    The importance of budget impact analyses in vaccination strategies, particularly for influenza and other vaccines, is gaining traction as public health priorities shift towards preventative healthcare.
  4. Integrated Care Models and Multi-Disease Approaches:
    Emerging studies are increasingly examining integrated care models that address multiple chronic conditions simultaneously, reflecting a holistic approach to patient management and economic evaluation.
  5. Use of Wearable Health Technologies:
    The assessment of wearable health technologies and their impact on patient management and health outcomes is becoming a prominent theme, driven by advancements in technology and patient engagement.

Declining or Waning

While the journal maintains a robust focus on health economics and therapeutic pathways, certain themes appear to be losing prominence in recent publications. This may reflect shifts in the healthcare landscape or emerging priorities in research.
  1. Traditional Cost-Benefit Analyses:
    There has been a noticeable decline in traditional cost-benefit analyses that do not incorporate broader patient-centered outcomes or real-world evidence, suggesting a shift towards more comprehensive evaluation frameworks.
  2. Generic Drug Assessments:
    Research specifically focused on the economic evaluation of generic drugs seems to be waning, potentially due to a saturation of studies in this area and a preference for innovative therapies.
  3. Single-Disease Focus Studies:
    There appears to be a reduction in studies concentrating solely on single-disease economic evaluations, with an increasing trend toward integrated care models that consider multiple conditions and their interactions.
  4. Basic Economic Modelling Techniques:
    The journal has seen fewer publications relying on basic economic modelling techniques, with a growing preference for sophisticated models that incorporate real-world complexities and uncertainties.

Similar Journals

Health Policy and Technology

Transforming healthcare through policy and innovation.
Publisher: ELSEVIER SCI LTDISSN: 2211-8837Frequency: 4 issues/year

Health Policy and Technology is a prestigious academic journal published by ELSEVIER SCI LTD that has established itself as a leader in the fields of Biomedical Engineering and Health Policy. With an impressive Q1 ranking in both disciplines as of 2023, the journal offers a platform for original research, reviews, and innovative technological solutions that aim to bridge the gap between health policy and technology. Since its inception in 2012, it has served as a vital resource for researchers, professionals, and students who are seeking to explore the impact of technology on healthcare systems and policies globally. Although it is not an open-access journal, the high-quality, peer-reviewed articles published within its pages contribute significantly to the discourse on the advancement of healthcare practices. The journal's commitment to disseminating groundbreaking studies ensures it remains a crucial reference point in these rapidly evolving fields.

JAMA Internal Medicine

Uncovering Innovations in Internal Medicine Scholarship
Publisher: AMER MEDICAL ASSOCISSN: 2168-6106Frequency: 12 issues/year

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

Journal of Comparative Effectiveness Research

Shaping the future of health policy through innovative research.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

MDM Policy & Practice

Advancing Health Policy Through Open Access Insights
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

MDM Policy & Practice is a premier open-access journal published by SAGE Publications Inc, focusing on the critical fields of Health Policy and Public Health, Environmental and Occupational Health. Since its inception in 2016, this journal has aimed to provide an authoritative platform for disseminating research findings, policy discussions, and innovative practices that drive improvements in health systems globally. With an impact factor that reflects its growing influence in the academic landscape, it holds a Q2 ranking in both Health Policy and Public Health categories as of 2023. This journal leverages its accessibility to foster a collaborative environment for researchers, policymakers, and practitioners alike, encouraging the exchange of ideas and knowledge to address pressing health challenges. Operating under a commitment to open access, MDM Policy & Practice ensures that vital research is available to a wider audience, fostering informed decision-making and progressive advancements in the health policy sphere.

Journal of Managed Care & Specialty Pharmacy

Empowering Professionals Through Open Access Knowledge
Publisher: ACAD MANAGED CARE PHARMACYISSN: 2376-0540Frequency: 12 issues/year

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.

Global & Regional Health Technology Assessment

Navigating the future of health technology together.
Publisher: ABOUTSCIENCE SRLISSN: 2284-2403Frequency: 1 issue/year

Global & Regional Health Technology Assessment (ISSN: 2284-2403; E-ISSN: 2283-5733) is an esteemed open-access journal published by ABOUTSCIENCE SRL, dedicated to the dissemination of research in the field of health technology assessment on a global and regional scale. Since its inception in 2014, this journal has focused on the critical evaluation of health technologies, providing invaluable insights into their efficacy, cost-effectiveness, and impact on healthcare systems. With an increasing emphasis on public health and policy implications, the journal encourages interdisciplinary research that bridges gaps between technological innovations and health outcomes. Despite its relatively recent establishment, it has made significant inroads with Scopus rankings reflecting the growing importance of health technology assessment in global health discourse. The journal welcomes contributions from researchers, professionals, and students, inviting them to engage in discussions that shape the future of health technology, with the aim of informing stakeholders and policymakers worldwide.

AMERICAN JOURNAL OF MANAGED CARE

Connecting evidence-based practices to real-world solutions.
Publisher: MANAGED CARE & HEALTHCARE COMMUNICATIONS LLCISSN: 1088-0224Frequency: 12 issues/year

AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.

Expert Review of Pharmacoeconomics & Outcomes Research

Empowering Pharmacoeconomics for Better Patient Outcomes
Publisher: TAYLOR & FRANCIS LTDISSN: 1473-7167Frequency: 6 issues/year

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

Health Policy OPEN

Advancing health policy through open dialogue.
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

Health Policy OPEN is an esteemed open-access journal published by Elsevier that has made significant contributions to the field of health policy since its inception in 2020. With an impact factor placing it in the prestigious Q2 category of health policy journals, it ranks 116 out of 310 within the Scopus database, highlighting its critical engagement in the field and situating it within the 62nd percentile. As an open-access platform, Health Policy OPEN promotes the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students alike. The journal focuses on topical issues, innovative approaches, and evidence-based practices that shape health policies worldwide. With its headquarters in Amsterdam, Netherlands, the journal serves as a vital resource for advancing knowledge and fostering discussions that drive health policy initiatives and reforms. Engage with Health Policy OPEN to contribute to the evolving landscape of health policy and to stay informed on the latest research advancements.

VALUE IN HEALTH

Connecting Research to Real-World Health Solutions
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.